June 2, 2021
It’s not too late! REGISTER NOW: SARC Semiannual Meeting
SARC Semiannual Virtual Meeting Friday, June 4, 20219:00 am–12:00 pm EDT Click REGISTER TODAY Registrants will receive a meeting link in advance of the virtual event.
Read more
May 24, 2021
Understanding Adoptive Cell Therapy for Sarcoma
Adoptive Cell Therapy is a type of cancer treatment that uses your own immune system to treat your cancer; it may be an option for patients with some types of …
Read moreMay 7, 2021
Message from SARC President & CEO
“I’d like to share an abridged view into some of SARC’s present and future research initiatives and strategic planning to evolve SARC’s collaborative model for even greater impact…Among the areas …
Read moreApril 23, 2021
SARC Meeting at ASCO 2021 June 4
Save the date! The SARC semiannual (virtual) meeting at ASCO, will be held the morning of Friday, June 4th, 9:00 am–noon Eastern Time.
Read moreApril 3, 2021
Sarcoma at NIH 2021 Rare Disease Day
Sarcoma was highlighted during 2021 Rare Disease Day at the National Institute for Health (NIH). Dr. Francis Collins, NIH Director noted “We’ve made real progress in these 10 years, first …
Read moreApril 2, 2021
Congratulations to Brigitte Widemann, MD
Congratulations to Brigitte Widemann, MD, for being named a Top Ten Clinical Research Achievement Awardee by the Clinical Research Forum and receiving a Distinguished Clinical Research Achievement Award for her …
Read moreMarch 19, 2021
Sarcoma Coalition March 2021 General Meeting
The Sarcoma Coalition welcomed Nilsa Ramirez, MD, Director of the Biopathology Center at the Abigail Wexner Research Institute at Nationwide Children’s Hospital to discuss patient advocacy considerations related to biospecimen …
Read moreMarch 9, 2021
A message from SARC Medical Officer Scott Okuno: Open Clinical Trials
Message (excerpt) from Dr. Okuno to SARC Members: SARC has several “open, active, enrolling clinical trials [including] extremity soft tissue sarcoma trial using radiation therapy and immunotherapy neoadjuvantly…for advanced metastatic …
Read moreJanuary 15, 2021
New Study in Ewing Sarcoma Open to Enrollment
SARC037 is a phase I study protocol to determine the recommended dose of trabectedin given as a 1-hour infusion in combination with low dose irinotecan. All patients enrolled will receive trabectedin combination …
Read moreDecember 10, 2020
Life Raft Group’s Recognizing Women in Sarcoma Gala
SARC celebrates Denise Reinke as she received the Women Paving the Path Forward Award at the Life Raft Group’s Recognizing Women in Sarcoma Gala. The Women in Sarcoma series highlights …
Read more